细胞骨架相关蛋白4(cytoskeleton-associated protein 4,CKAP4)即p63,是一种非糖基化的Ⅱ型膜蛋白。CKAP4在组织、细胞以及血清中的表达可作为多种肿瘤的诊断性标志物,并与这些肿瘤的预后有一定相关性。该文对CKAP4的亚型和功能,以及CK...细胞骨架相关蛋白4(cytoskeleton-associated protein 4,CKAP4)即p63,是一种非糖基化的Ⅱ型膜蛋白。CKAP4在组织、细胞以及血清中的表达可作为多种肿瘤的诊断性标志物,并与这些肿瘤的预后有一定相关性。该文对CKAP4的亚型和功能,以及CKAP4作为肿瘤诊断性、预后性指标的研究及应用进行了综述。展开更多
目的大多数急性缺血性卒中患者难以在发病早期接受静脉溶栓治疗,而移动卒中单元(mobile stroke unit,MSU)的应用将静脉溶栓治疗从院内提到院前。本研究初步探讨中国首台MSU在急性卒中患者院前静脉溶栓中的作用。方法回顾性分析荥阳市人...目的大多数急性缺血性卒中患者难以在发病早期接受静脉溶栓治疗,而移动卒中单元(mobile stroke unit,MSU)的应用将静脉溶栓治疗从院内提到院前。本研究初步探讨中国首台MSU在急性卒中患者院前静脉溶栓中的作用。方法回顾性分析荥阳市人民医院卒中中心2018年11月-2019年4月期间应用MSU进行院前静脉溶栓的患者(MSU溶栓组)和使用传统救护车转运至院内静脉溶栓的患者(常规溶栓组)的临床资料。观察终点包括主要时间指标从呼叫至溶栓时间、从发病至溶栓时间;疗效指标为90 d良好预后(mRS评分≤2分)率;安全性指标包括溶栓后48 h内症状性颅内出血及随访90 d内的全因死亡。比较静脉溶栓患者应用两种治疗模式的终点差异。结果MSU溶栓组共计14例患者接受了院外静脉溶栓,同时期常规溶栓组有24例患者在院内进行了静脉溶栓治疗。与常规溶栓组相比,MSU溶栓组呼叫至溶栓时间(59 min vs 92 mi n,P=0.001)、发病至溶栓时间(73 min vs 114 mi n,P=0.002)均较短。两组的90 d良好预后率(79%vs 67%,P=0.488)和安全性指标均未见统计学差异。结论基于MSU的急性缺血性卒中院前溶栓可以显著缩短患者从发病至溶栓时间及呼叫至溶栓时间,但对于急性卒中的救治疗效仍需要多中心前瞻性研究进一步验证。展开更多
To improve Mixograph testing effect, Farinograph measurements were adopted as a quality standard and changes in water absorption and parameter conversion in Mixograph test were explored. Comparative study showed that ...To improve Mixograph testing effect, Farinograph measurements were adopted as a quality standard and changes in water absorption and parameter conversion in Mixograph test were explored. Comparative study showed that increasing water absorption to about 73% and converting original parameters to compound parameters in Mixograph tests signiifcantly increased their predictive power for lfour quality. These efforts also enabled the adoption of ifxed water addition level in Mixograph test and simpliifed the test procedure signiifcantly. With the success in parameter conversions, Mixograph test results were successful y described by Farinograph parameters, which al ow breeders to compare and exchange test results easily. Al these changes optimized the ofifcial method of Mixograph test with simpliifed procedure and enhanced reliability and made the Mixograph being the superior tool for quality assessment in wheat-breeding programs.展开更多
文摘细胞骨架相关蛋白4(cytoskeleton-associated protein 4,CKAP4)即p63,是一种非糖基化的Ⅱ型膜蛋白。CKAP4在组织、细胞以及血清中的表达可作为多种肿瘤的诊断性标志物,并与这些肿瘤的预后有一定相关性。该文对CKAP4的亚型和功能,以及CKAP4作为肿瘤诊断性、预后性指标的研究及应用进行了综述。
文摘目的大多数急性缺血性卒中患者难以在发病早期接受静脉溶栓治疗,而移动卒中单元(mobile stroke unit,MSU)的应用将静脉溶栓治疗从院内提到院前。本研究初步探讨中国首台MSU在急性卒中患者院前静脉溶栓中的作用。方法回顾性分析荥阳市人民医院卒中中心2018年11月-2019年4月期间应用MSU进行院前静脉溶栓的患者(MSU溶栓组)和使用传统救护车转运至院内静脉溶栓的患者(常规溶栓组)的临床资料。观察终点包括主要时间指标从呼叫至溶栓时间、从发病至溶栓时间;疗效指标为90 d良好预后(mRS评分≤2分)率;安全性指标包括溶栓后48 h内症状性颅内出血及随访90 d内的全因死亡。比较静脉溶栓患者应用两种治疗模式的终点差异。结果MSU溶栓组共计14例患者接受了院外静脉溶栓,同时期常规溶栓组有24例患者在院内进行了静脉溶栓治疗。与常规溶栓组相比,MSU溶栓组呼叫至溶栓时间(59 min vs 92 mi n,P=0.001)、发病至溶栓时间(73 min vs 114 mi n,P=0.002)均较短。两组的90 d良好预后率(79%vs 67%,P=0.488)和安全性指标均未见统计学差异。结论基于MSU的急性缺血性卒中院前溶栓可以显著缩短患者从发病至溶栓时间及呼叫至溶栓时间,但对于急性卒中的救治疗效仍需要多中心前瞻性研究进一步验证。
基金financially supported by the Knowledge Innovation Program from the Chinese Academy of Sciences (KSCX2-EW-N-02)the State Key Laboratory of Plant Cell and Chromosome Engineering,Ministry of Science and Technology of China
文摘To improve Mixograph testing effect, Farinograph measurements were adopted as a quality standard and changes in water absorption and parameter conversion in Mixograph test were explored. Comparative study showed that increasing water absorption to about 73% and converting original parameters to compound parameters in Mixograph tests signiifcantly increased their predictive power for lfour quality. These efforts also enabled the adoption of ifxed water addition level in Mixograph test and simpliifed the test procedure signiifcantly. With the success in parameter conversions, Mixograph test results were successful y described by Farinograph parameters, which al ow breeders to compare and exchange test results easily. Al these changes optimized the ofifcial method of Mixograph test with simpliifed procedure and enhanced reliability and made the Mixograph being the superior tool for quality assessment in wheat-breeding programs.
